SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-005762
Filing Date
2024-04-25
Accepted
2024-04-25 16:05:10
Documents
5
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A xlo-20240613xdef14a.htm DEF 14A 778697
2 GRAPHIC xlo-20240613xdef14a_a003.jpg GRAPHIC 9237
3 GRAPHIC xlo-20240613xdef14a_a004.jpg GRAPHIC 1490
4 GRAPHIC xlo-20240613xdef14a_bg001.jpg GRAPHIC 121108
5 GRAPHIC xlo-20240613xdef14a_bg002.jpg GRAPHIC 104056
  Complete submission text file 0001558370-24-005762.txt   1105196
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40925 | Film No.: 24876172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)